We are hiring a Clinical Research Nurse or Clinical Research Practitioner! We have two posts available based in London and Manchester to work on the upcoming FORWARDS-2 trial. Please RT. London site: Manchester site:

We won! . Our Addiction Team received the Reward and Recognition Award for the category Public Engagement for our contributions to the Imperial Lates: Drug Experiments event. It was a great evening and we were all buzzing afterwards! . Thank you to everyone who came along!.

Tonight on BBC1 @mattjwillis shares his experience of addiction and the impact on his loved ones. Tune in at 9pm to see him chat with @DrLMPaterson about the work we’re doing and how it may help those affected.

RT @addmarksweeney: Congrats on winning the best presentation prize at @SSA_Addiction conference, Dr Paterson! . @ICL_Addiction https://t.c….

We had a great time today at the #ecraddictions2023 conference presenting our findings from the NCORE & FORWARDS studies. A big congratulations to our very own @DrLMPaterson who won the best oral presentation award!.& thank you to the organisers! @SSA_Addiction @KingsAddictions

Come and chat to us at #ImperialLates!! We’re over at stand 5, ready to answer all your addiction and drug related questions 🧠 @ImperialBrains

Come & join us at the upcoming Imperial Lates event to find out more about drug experiments. We'll be chatting all things substance use & addiction with some great artwork & interactive activities. Get your free tickets here 👉 @imperialcollege

One of our PhD students @Dr_K_Herlinger presented her findings on the NCORE study at the @LxAddictions conference last week. Follow the link to read more! #LxAddictions22

We were at the #ssaconf22 this year! What a great time talking to everyone about their research and learning from each other about the latest developments in addiction research. We look forward to next time! Thank you @SSA_Addiction!

Check out the protocol of our current study FORWARDS-1, an adaptive, single-blind, placebo-controlled ascending dose study of acute baclofen in methadone-maintained opioid dependence.

Interesting new paper from our research assistant @joannavamvako looking at the effect of selective D3 antagonism on BOLD response to aversive image processing in drug-dependent individuals. @FrontPsychiatry.

Dame Carol Black recently visited our lab to find out about our research to improve the understanding and treatment of addiction. If you’re interested, you can read more about her visit here: .

We’ve been busy this conference season presenting some of our research at @FENSorg, @SOBP @BAPsych - check out our posters looking at all things addiction 🧠 @LexiJHand @LexiHayes17

We're hiring!! 🧠 We are looking for an experienced clinical trials manager to join our multidisciplinary team at Imperial College London. Interested? find out more by following the link. @ImpPsych @ImperialMed @imperialcollege.

The FORWARDS study makes use of a novel, adaptive, dose-finding design to assist with dose escalation decisions. The design of the model has now been published in Pharmaceutical Statistics: the Journal of Applied Statistics in the Pharmaceutical Industry.

Check out our blog post explaining the background and aims of our most recent study - FORWARDS, investigating the safety and proof-of-concept efficacy of baclofen to support detoxification from methadone in opiate dependence.

RT @SSA_Addiction: Prof. Anne Lingford-Hughes is discussing clinical research post-Brexit #SSAConf2021.

Take a look at our new review in @Nutrients_MDPI looking at the effects of alcohol on the brain with a specific focus on Neuroimaging. @ProfDavidNutt @RayyanZafar6 @Leon_Fonville @LexiHayes17 @ImpPsych @ImperialMed.

We just joined LinkedIn! Follow us at

We are still looking for healthy control volunteers for our study NCORE! Are you or is someone you know a current or ex-smoker, 30+ years old and based in Greater London and surrounding areas? Learn more at or email us at cfn.recruitment@imperial.ac.uk.